glp-1 weight loss program framingham THE MICRODOSING GLP-1 Therapy Part 1: Setting

The SURPASS program, which evaluated tirzepatide in patients with type 2 diabetes across diverse treatment settings, consistently showed superior reductions in glycated hemoglobin compared with established therapies, including basal insulin and selective GLP 1 receptor agonists

Owing to the number of GLP1RAs available, and because of its clinical efficacy compared with other GLP1RAs, this review will focus on switching to OW semaglutide because this will highlight the main clinical considerations for switching

Lyophilized (freeze-dried) vials contain peptide powder that must be reconstituted with bacteriostatic water before usethese are stable at 20C for 1224 months before reconstitution

The augmentation of iron intake, the decline in stored iron, and the alleviation of iron outflow can lead to increased Fe 2+ in the LIP in cells